The Breyers launch comes hot on the heels of Nestlé’s ‘Better Whey’ product from Orgain, which features whey protein made by microbes in fermentation tanks instead of cows.
Brightseed is a pioneer in biosciences and artificial intelligence (A.I.) that illuminates nature to restore human health. Brightseed’s proprietary A.I., Forager®, accelerates bioactive discovery, biological
Description Headquartered in St. Paul, Minnesota, Sentera builds specialized software, analytics, cameras and drones that capture and integrate in-field data insights and images with digital
“This strategy aligns with our commitment to scaling up responsibly,” says CEO Didier Toubia.
Bangalore-based FaunaTech is a novel smartphone-based diagnostics platform for rapid testing of milk and bovine health at the farmgate.
Less than five months after announcing its first commercial-scale cultivated meat plant in Glenview, Illinois, UPSIDE Foods has hit pause…
Founded by ex-Impossible Foods exec Reed McCord, First Bite is a data platform designed for food manufacturers looking to increase sales in the foodservice channel.
Funding for cultivated meat peaked at $989m in 2021, dipped slightly to $807m in 2022, then dropped sharply to just $177m in 2023.
“Your gut barrier is a one or two cell membrane that separates your nutrition from your waste, so when you think about it in those terms, it’s pretty stark why you want it to function optimally,” says Brightseed.
Finless Foods is not commenting on rumors that it is reducing headcount to extend runway, raise capital, and rebuild at a later time.
African Agriculture aims to transform the Sahel’s beef and dairy industries through the production of animal feed.
According to its CEO: “We still have quite a bit of runway as we’ve been very lean. Part of that is because we’ve never invested in large-scale production capacity [in-house] and we’ve never entered the B2C world.”
While we hope that investors in our space have come to terms with some of the longer timeframes needed to establish and scale companies, you can’t count on that anymore, writes AFN editor.
But does it make sense to grow a commodity ingredient such as coffee in a bioreactor, or does plant cell culture only make sense for ultra-high-value botanicals such as saffron?
How efficient are bugs at creating bags, and how scalable is Modern Synthesis’ patent-pending biomaterials technology?
Agrifood VC funds grew from 42 in 2013 to more than 280 by the third quarter of 2023, though that growth has slowed in the last few years.
At a time when many alt protein companies are struggling to raise funds, Infinite Roots (formerly Mushlabs) has netted $58m from investors including German food retail giant (REWE) and the holding company behind Haribo (HRH).
The capital injection will also help advance work to develop Cavendish bananas engineered to resist the devastating fungal disease Fusarium wilt.
Are GLP-1 drugs an ‘existential threat’ to the food industry or an opportunity for some creative thinking?
We’re kidding ourselves if we think we can make the unit economics add up for cultivated meat without deploying ‘much much larger’ bioreactors, says Ark Biotech.
